Business Advisory Board
Rachel Humphrey
Scientific Advisory Board
- Currently serves as the CEO of a new venture
- Serves on the Board of Xilio Therapeutics
- Previously served as CMO of Black Diamond Therapeutics, VP and SVP roles at Bristol Myers Squibb (ipilimumab), Bayer (sorafenib), Cytomyx, AstraZeneca, Eli Lilly